1. Home
  2. ACNT vs TTRX Comparison

ACNT vs TTRX Comparison

Compare ACNT & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Industries Co.

ACNT

Ascent Industries Co.

HOLD

Current Price

$13.92

Market Cap

133.2M

Sector

Industrials

ML Signal

HOLD

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$4.01

Market Cap

107.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACNT
TTRX
Founded
1945
2015
Country
United States
United States
Employees
N/A
2
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.2M
107.2M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
ACNT
TTRX
Price
$13.92
$4.01
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
69.2K
19.2K
Earning Date
05-06-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
106.72
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.62
$2.57
52 Week High
$17.92
$5.98

Technical Indicators

Market Signals
Indicator
ACNT
TTRX
Relative Strength Index (RSI) 46.96 68.92
Support Level $13.66 $3.55
Resistance Level $16.80 $4.40
Average True Range (ATR) 0.54 0.20
MACD -0.11 0.04
Stochastic Oscillator 45.73 90.41

Price Performance

Historical Comparison
ACNT
TTRX

About ACNT Ascent Industries Co.

Ascent Industries Co is a specialty chemicals company focused on the development, production, and distribution of tailored, performance-driven chemical solutions. Its customers are spread across energy, household, industrial and institutional (HII), personal care, coatings, adhesives, sealants and elastomers (CASE), agriculture, water treatment, pulp and paper, construction, automotive, and other industrial markets. The company's core product portfolio includes surfactants, defoamers, lubricating agents, flame retardants, and specialty intermediates, offered in both petroleum-based and bio-based formulations. Geographically, it generates maximum revenue from the United States, followed by Mexico, Canada, Honduras, Colombia, the Netherlands, Costa Rica, Japan, and other markets.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: